An exciting opportunity has arisen in Blood Sciences within the NHS East and South East London Pathology Partnership (ESEL). We a.....
An exciting opportunity has arisen in Blood Sciences within the NHS East and South East London Pathology Partnership (ESEL). We are a new organisation, jointly owned by Barts Health NHS Trust, Homerton University Hospital NHS Foundation Trust and Lewisham and Greenwich NHS Trust. Set up as an arms-length organisation, hosted by Barts Health NHS Trust, we have our own board and governance framework, with each of the three trusts having an equal voice and vote in the running of the Pathology Partnership. One of the largest pathology providers in the NHS, the Pathology Partnership brings together the strengths of teams from each of the three trusts into a single organisation, dedicated to the provision of high quality and cost-effective pathology services.
A comprehensive transformation initiative is underway to forge a single, integrated pathology network spanning seven hospital laboratories. The envisioned 'hub and spoke' operational model revolves around The Royal London Hospital (RLH), a major trauma centre housing the London Air Ambulance, and linked to vital service laboratories supporting various clinical specialties across our affiliated hospital sites.
The expansive network of laboratories within the NHS presents an invaluable opportunity for acquiring extensive technical and leadership expertise. ESEL acknowledges the significance of career advancement and efficient succession planning.
This is an exciting opportunity to join a forward thinking and innovative service. Bring to fruition a vision of delivering high quality training and competency assessment through an electronic learning management system for one of the largest networked laboratories within the NHS.
We are looking to appoint a dynamic and highly motivated Specialist Biomedical Scientist Training Officer (Band 7) who has expertise in laboratory training and emerging training modalities.
While based at the Royal London Hospital, the successful Band 7 candidate is expected to work in different work areas and across the ESEL laboratories.
Successful Band 7 candidatesMUSTbe registered with the HCPC as a Biomedical ScientistANDhold the following
· CPSM Log book (Clinical Biochemistry) if qualified before 2003.
OR
Registration portfolio IBMS (Clinical Biochemistry2003 to 2004)andDiploma in Biomedical Science IBMS (Blood Sciences 2005).
OR
· Specialist Diploma IBMS (Clinical Biochemistry2005 onwards)
AND
· Fellowship (Clinical Chemistry), MSc Biomedical Science or equivalent qualification at MSc level.
Compliance to these criteria is mandatory and must be clearly recorded on application.
The NHS East and South East London Pathology Partnership is an arms-length organisation providing pathology services to Barts Health NHS Trust, Homerton University Hospital NHS Foundation Trust and Lewisham and Greenwich NHS Trust. The Pathology Partnership is hosted by Barts Health.
The Pathology Partnership is based on well-established models for pathology networks, with the Royal London Hospital becoming the main hub laboratory for the network and Essential Service Laboratories (ESL) as a minimum at all other Hospital sites.
Pathology is made up of the following services - Blood Sciences including Haematology, Blood Transfusion and Biochemistry; Infectious Diseases including Microbiology and Virology; Cellular Pathology including Histopathology, non-gynae Cytology and mortuary services; Immunology; Cytogenetics and Molecular Haematology; Immunophenotyping; Clinical Transplantation and Retinoblastoma.
The 2020/21 total operating costs across the Partnership were c. £126m per annum with a workforce establishment of circa. 822 WTE. We strive to live by our WeCare values and are committed to promoting inclusion, where every staff member has a sense of belonging. We value our differences and fully advocate, cultivate and support an inclusive working environment.
The full job description provides an overview of the key tasks and responsibilities of the role, and the person specification outlines the qualifications, skills, experience, and knowledge required. For both documents, please view the attachment/s below.
If you require further information or would like to arrange an informal visit please contact
Greg Dearman, Biochemistry Scientific Lead: 0203 246 0443
(Greg.Dearman@nhs.net)
Please note: -
All staff identified as AT-RISK who meet the requirements of the post will be prioritised accordingly. Priority will initially be given to Barts Health employees. This does not apply to Comprehensive Local Research Network (CLRN) roles.
As an Equal Opportunities Employer we actively support applications from individuals’ who apply under the Guaranteed Interview Scheme and will process your application as appropriate. To demonstrate our commitment we use the disability symbols on NHS Jobs.
We reserve the right to expire vacancies prior to the advertised closing date once a sufficient number of applications has been received and we regret that we are unable to provide notification if your application is unsuccessful.
All new appointments (excluding all Medical & Dental doctors) are subject to 6 months’ probation period.
In submitting an application form, you authorise Barts Health to confirm any previous NHS service details via the Electronic Staff Record Inter Authority Transfer process should you be appointed to the post.
All vacancies followed by INTERNAL ONLY, have been classified as an internal role and only internal candidates will be considered.
If you are successful at the shortlisting stage we will contact you via NHS Jobs e-Mail and text message with details of your interview. Please continue to check your e-Mails and also your NHS Jobs account for correspondence.
Barts Health is committed to safeguarding the welfare of children and to child protection. The Trust aims to ensure as far as is possible that anyone, paid or unpaid, who seeks to work in our organisation and who gains access to children, is safe to do so.
This advert closes on Wednesday 14 Aug 2024